Improvement of Lower Facial Shape After Treatment With OnabotulinumtoxinA: Secondary Results From a Phase 2 Dose Escalation Study
{{output}}
Background: Masseter muscle prominence (MMP) contributes to a widened lower facial shape, considered aesthetically undesirable to some individuals. This study assessed lower facial shaping improvements with onabotulinumtoxinA. ... ...
